2014
DOI: 10.1186/1755-1536-7-12
|View full text |Cite
|
Sign up to set email alerts
|

Lipid mediators in diabetic nephropathy

Abstract: The implications of lipid lowering drugs in the treatment of diabetic nephropathy have been considered. At the same time, the clinical efficacy of lipid lowering drugs has resulted in improvement in the cardiovascular functions of chronic kidney disease (CKD) patients with or without diabetes, but no remarkable improvement has been observed in the kidney outcome. Earlier lipid mediators have been shown to cause accumulative effects in diabetic nephropathy (DN). Here, we attempt to analyze the involvement of li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
45
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 61 publications
(45 citation statements)
references
References 73 publications
0
45
0
Order By: Relevance
“…Metabolic syndrome, which may represent a risk factor for AD in some patients [43], can lead to elevated DAG levels via augmented glycolysis [44]. However, hyperglycemia was not a factor in our MCI and AD cohorts, indicating that this is a minor source for increased circulating levels of DAGs.…”
Section: Discussionmentioning
confidence: 86%
“…Metabolic syndrome, which may represent a risk factor for AD in some patients [43], can lead to elevated DAG levels via augmented glycolysis [44]. However, hyperglycemia was not a factor in our MCI and AD cohorts, indicating that this is a minor source for increased circulating levels of DAGs.…”
Section: Discussionmentioning
confidence: 86%
“…Furthermore, it has been reported that plasma ceramides are elevated in obese patients with type 2 diabetes mellitus [10]. Most ceramide studies have focused on insulin resistance in the liver, muscle, and adipose tissue; only few have associated increased ceramide levels with renal injury, and most reports on diabetic nephropathy have used extrapolated data from plasma ceramide levels [11][12][13].…”
Section: Introductionmentioning
confidence: 99%
“…2-5 For example, lipids are essential in the regulation of blood vessel permeability, 6 blood clotting, 7,8 diabetic nephropathy, 9 and apoptosis. 10 One particularly fascinating aspect of lipid behavior is the effect that hydration has on lipid function.…”
Section: Introductionmentioning
confidence: 99%